https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-01 / Ai Zheng 2006 May;25(5):625-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-01 / Ai Zheng 2006 May;25(5):625-302006-05-01 00:00:002019-02-15 08:48:11[Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma–a report of ten cases]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-18 / Eur. Urol. 2006 Jul;50(1):34-43
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-18 / Eur. Urol. 2006 Jul;50(1):34-432006-04-18 00:00:002019-02-15 09:17:02Therapeutic dendritic cell vaccination of patients with renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-02-01 / Clin Cancer Res 2006 Feb;12(3 Pt 1):869-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-02-01 / Clin Cancer Res 2006 Feb;12(3 Pt 1):869-772006-02-01 00:00:002006-02-01 00:00:00Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-27 / Cancer Immunol. Immunother. 2006 Jan;55(1):63-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-27 / Cancer Immunol. Immunother. 2006 Jan;55(1):63-72005-10-27 00:00:002019-02-15 09:17:04Dendritic cell-based cancer immunotherapy targeting MUC-1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-06-15 / Pediatr Blood Cancer 2005 Jun;44(7):679-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-06-15 / Pediatr Blood Cancer 2005 Jun;44(7):679-812005-06-15 00:00:002019-02-15 09:17:05Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-12-17 / Cancer Immunol. Immunother. 2005 Jul;54(7):663-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-12-17 / Cancer Immunol. Immunother. 2005 Jul;54(7):663-702004-12-17 00:00:002019-02-15 09:17:04Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-03-01 / J. Urol. 1999 Mar;161(3):777-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-03-01 / J. Urol. 1999 Mar;161(3):777-821999-03-01 00:00:002019-02-15 08:48:12Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-01-01 / Urol Int 1999;63(3):151-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-01-01 / Urol Int 1999;63(3):151-91999-01-01 00:00:001999-01-01 00:00:00Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
